Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand ; volume:17 ; number:1 ; day:10 ; month:2 ; year:2017 ; pages:1-9 ; date:12.2017
Cancer cell international ; 17, Heft 1 (10.2.2017), 1-9, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Oh, Se-Jeong
- Beteiligte Personen und Organisationen
-
Yang, Jung-In
Kim, Ok
Ahn, Eun-Jung
Kang, Woo Dae
Lee, Jae-Hyuk
Moon, Kyung-Sub
Lee, Kyung-Hwa
Cho, Duck
SpringerLink (Online service)
- DOI
-
10.1186/s12935-017-0397-7
- URN
-
urn:nbn:de:1111-2017030525706
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Oh, Se-Jeong
- Yang, Jung-In
- Kim, Ok
- Ahn, Eun-Jung
- Kang, Woo Dae
- Lee, Jae-Hyuk
- Moon, Kyung-Sub
- Lee, Kyung-Hwa
- Cho, Duck
- SpringerLink (Online service)
Ähnliche Objekte (12)
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
Targeting senescent cells with NKG2D-CAR T cells
Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity
Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression
Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity
Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen
Autophagic control of cell ‘stemness’
Proteolytic shedding of NKG2D ligands from tumour cells : = Proteolytische Freisetzung von NKG2D-Liganden durch Tumorzellen
Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation
Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications
Protein quality control of cell stemness
Neural stemness contributes to cell tumorigenicity
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
Targeting senescent cells with NKG2D-CAR T cells
Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity
Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression
Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity
Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen
Autophagic control of cell ‘stemness’
Proteolytic shedding of NKG2D ligands from tumour cells : = Proteolytische Freisetzung von NKG2D-Liganden durch Tumorzellen
Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation
Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications
Protein quality control of cell stemness
Neural stemness contributes to cell tumorigenicity
TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
Targeting senescent cells with NKG2D-CAR T cells
Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity
Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression
Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity
Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen
Autophagic control of cell ‘stemness’
Proteolytic shedding of NKG2D ligands from tumour cells : = Proteolytische Freisetzung von NKG2D-Liganden durch Tumorzellen
Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation
Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications
Protein quality control of cell stemness